| Recruiting | A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Plati Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | Phase 2 | 2024-10-11 |
| Active Not Recruiting | Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Ovarian Cancer, Low Grade Serous Carcinoma, Primary Peritoneal Carcinoma | Phase 2 | 2022-02-22 |
| Completed | Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ova Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | Phase 3 | 2020-06-08 |
| Active Not Recruiting | Pazopanib Vs. Pazopanib Plus Gemcitabine Leiomyosarcoma or Carcinosarcoma | Phase 2 | 2019-10-16 |
| Active Not Recruiting | Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer Primary Invasive Breast Cancer, Estrogen Receptor Positive Tumor, Human Epidermal Growth Factor Receptor 2 Negative Tumor | — | 2018-07-17 |
| Terminated | QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Ca Quality of Life, Ovarian Cancer, Recurrent Ovarian Carcinoma | Phase 4 | 2018-02-01 |
| Completed | Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse Ovarian Cancer | Phase 3 | 2007-03-01 |
| Completed | Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer Ovarian Cancer | Phase 2 | 2005-09-01 |
| Completed | Preference Study With Elderly Patients Recurrent Ovarian Cancer Ovarian Cancer | Phase 3 | 2004-08-01 |
| Completed | Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer Ovarian Cancer | Phase 1 / Phase 2 | 2004-06-01 |
| Completed | Taxol Carboplatin and Erythropoetin Ovarian Cancer | Phase 2 | 2003-07-01 |
| Completed | Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer Ovarian Cancer | Phase 2 | 2001-09-01 |
| Completed | Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes Breast Cancer | Phase 3 | 2000-03-01 |
| Completed | Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy Ovarian Cancer | Phase 3 | 2000-01-01 |
| Completed | Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer Ovarian Cancer | Phase 2 | 1999-01-01 |